What happened
Kainos Medicine updated a previously disclosed supply contract with LT9 Enterprises Limited, now worth US$672K, about 167.78% of its recent annual revenue, running through May 2026.
For context, this single contract equals about 167.78% of the company's most recent annual revenue.
| Counterparty | LT9 Enterprises Limited |
|---|---|
| Contract value | US$672K |
| vs. recent revenue | 167.78% |
| Through | May 2026 (from May 2025) |
| Filed | 2026-04-30, [Amended] Supply contract signed |
| Source | DART rcept 20260430900993 → open original filing |
Source: DART. Information only, not investment advice.